NEUP: Neuphoria Therapeutics, Inc. Narx/daromad koeffitsiyenti

Neuphoria (NEUP) tovar belgisi

Nevropreparatlarni ishlab chiqishning murakkabligi va FDA ning qat'iy nazorati kirish uchun sezilarli to'siqlarni yaratadi. Kompaniya qiymatining yillik daromadga nisbati joriy baholash dinamikasini ko'rsatadi, bunda ko'rsatkich darajasi 11.50 ni tashkil etadi. Neuphoria Therapeutics Inc. (NEUP) BNC210 asosida bog'liqlikni keltirib chiqarmaydigan PTSD davolash vositasini ishlab chiqmoqda, biroq laboratoriya xarajatlarining yuqoriligi sababli portfelni kengaytirish doimiy kapital olqishlarni talab qiladi.

Kapitalizatsiyaning daromadga nisbati: Neuphoria Therapeutics, Inc. (NEUP) 25.01.2025 - 17.11.2026 uchun

Neuphoria Therapeutics, Inc. (NEUP) kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:NEUP - Neuphoria Therapeutics Inc.
Neuphoria Therapeutics brendining mahsuloti

P/S koeffitsiyenti Neuphoria Therapeutics Inc. (NEUP) kompaniyasining bozor kapitalizatsiyasi va uning yillik daromadi o'rtasidagi bog'liqlikni aks ettirib, sotuvlarning har bir birligi uchun xarajatni o'lchaydi. Kompaniyaga tegishli P/S koeffitsiyentini tahlil qilish investorga aktivning tarixiy o'rtacha ko'rsatkichlarga nisbatan haddan tashqari sotib olinganligini baholash imkonini beradi. Ushbu chiziqning narx harakati maksimal xavfsiz boshpana marjasi bilan kirish nuqtalarini aniqlashga yordam beradi. Xavotir buzilishlarini davolovchi olimlar jamoasiga investitsiya kiritayotgan biotexnologiya startapi uchun ushbu ko'paytiruvchi kelajakdagi tijorat muvaffaqiyatiga bo'lgan bozor kutuvlarining ko'rsatkichi bo'lib xizmat qiladi.

Neuphoria Therapeutics Inc. raqobatchilari

BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning daromadga nisbati|CervoMed Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc)|P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati metaviatx.com (MTVA)|P/S multiplikatori NRXS|HSDT - Sotuvga nisbatan narx|Passage Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati